Skip to main content
Caplight Logo









Eolas Medical

Eolas Medical

Private
BelfastHealthcare & Life Scienceshttps://eolasmedical.com/en-us

Last Round

Series A

Jan 19, 2026

Est. Valuation

$40.38M

Total Funding Raised

$14.75M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Eolas Medical is a health-tech company that provides an AI-enabled clinical knowledge infrastructure platform to help healthcare systems and clinicians access institution-specific guidelines and protocols at the point of care.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Document Management

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical knowledge managementclinical decision supportCDSSclinical guidelinespoint of carehealthcare SaaSclinical governancemedical protocol managementclinical workflow automationhospital softwareAI clinical assistantdigital health platformmedical knowledge baseclinical documentationmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eolas Medical Comparables

Compare Eolas Medical with similar companies based on industry and business-model similarity.

Eolas Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wolters Kluwer
74%
British Medical Association
71%
EvidenceCare
69%

Eolas Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 19, 2026
SeedMar 12, 2021

Eolas Medical Investors

Notable investors and investment history

Eolas Medical investors
InvestorRounds
Ascension VenturesSeries A, Seed
ScaleX InvestmentsSeries A
Whiterock Capital PartnersSeries A
Portfolio VenturesSeries A
SamaipataSeries A, Seed
7 Percent VenturesSeed
Acton CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 42% MoM, reaching 59.8K.

  • Jul 15, 2026

    Grew 33% QoQ, from 15 to 20 employees.

Eolas Medical Filings

Explore SEC and related filing metadata, where available.

Eolas Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eolas Medical's valuation, stock price, and market status.

Is Eolas Medical a public or private company?

Eolas Medical is a private company.

What is the current stock price of Eolas Medical?

Eolas Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Eolas Medical worth (valuation)?

Eolas Medical's valuation is estimated at $40.4M based on funding round data.

Can I buy Eolas Medical stock?

Eolas Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eolas Medical's last funding round?

Eolas Medical's most recent funding round was Series A on January 19, 2026.

Who are the main investors in Eolas Medical?

Key investors in Eolas Medical include Samaipata, Acton Capital.

Will Eolas Medical IPO soon?

No public IPO plans have been announced for Eolas Medical.

How can I track Eolas Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eolas Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelfast
Employee Range21
Year Founded2019
Last FundingJan 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?